Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Cairn Homes maintains guidance as demand stays strong

(Sharecast News) - Irish homebuilder Cairn Homes has reiterated its full-year guidance after a strong start to the year, saying demand for new homes remains "exceptionally high", as it reported a forward order book of more than €1bn. The current forward order book stands at €1.05bn, representing 2,750 new homes, 1,000 of which will be delivered in 2025 and beyond.

This was up from a forward order book of €946m and 2,473 homes on 29 February when it published its annual results.

"The demand backdrop for our well located, energy efficient new homes remains exceptionally high across all tenure types," the company is expected to say at its annual general meeting in Dublin on Friday.

"In our core first time buyer market, State supports for our customers, a more favourable mortgage market and the limited supply of competitively priced starter homes are driving the positive momentum in our business."

Cairn said it continues to expect to deliver 2,200 units in 2024, compared with 1,741 sales completions in 2023. It also is targeting an operating profit of €145m, up from €113.4m in 2023, with a return on equity of 15%, up from 11% previously.

"We are pleased that our housing output will grow by nearly 30% this year and our forward order book of in excess of €1 billion is a testament to the exceptional demand for our homes," said chief executive Michael Stanley.

"What is equally pleasing is that the broader industry is ramping up completions and government initiatives are working."

Shares were up 2% at 143.87p by 0907 BST.

Share this article

Related Sharecast Articles

Hvivo scores £2.5m contract for Omicron characterisation study
(Sharecast News) - Contract research organisation Hvivo has secured a £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicron characterisation study after the manufacture of its Omicron BA.5 challenge agent was successfully completed in 2023.
MP Evans purchases minority stakes in Indonesian subsidiaries
(Sharecast News) - Palm oil producer MP Evans has purchased a 5% minority holding in the majority of its Indonesian subsidiary trading companies.
JPMorgan upgrades St James's Place, Quilter to 'overweight'
(Sharecast News) - JPMorgan Cazenove upgraded St James's Place and Quilter to 'overweight' from 'neutral' on Monday as it took a look at UK wealth managers.
Shein eyeing potential London listing
(Sharecast News) - Fast fashion retailer Shein will file paperwork for a potential floatation on the London Stock Exchange as soon as this week, according to Sky News, with an initial public offering potentially valuing the firm at roughly £51.7bn.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.